Highlights

In brief

Researchers map thousands of cis-regulatory elements involved in liver gene expression that are responsive to gut microbes and their metabolites, showing how this crosstalk could affect liver health and disease.

Photo by CDC | Unsplash

Liver genes listen to the gut

13 Nov 2026

In liver cells, the DNA switches that control gene activity obey a higher commander—chemical signals from gut bacteria.

As our digestive organs work together, a large blood vessel runs from the gut to the liver, relaying nutrients, toxins and chemical signals. This blood flow constantly exposes liver cells to chemical compounds, also called metabolites, produced by bacteria in the gut.

Listening to the microbes’ signals, stretches of DNA called cis-regulatory elements (CREs) respond by adjusting the activity of liver cell genes. “We can think of CREs as the control switches that turn specific genes on and off,” said Poshen Benson Chen, a Principal Investigator at the A*STAR Genome Institute of Singapore (A*STAR GIS).

Such molecular interactions could help explain why disturbances in the gut microbiome have been linked to liver diseases like metabolic dysfunction-associated fatty liver disease (MAFLD) and liver cancer. But how gut microbe-derived metabolites influence specific liver CREs and the resulting gene activity has remained unclear.

To uncover this gut-liver crosstalk, Chen led a multi-institutional team from A*STAR GIS, Nanyang Technological University and National University of Singapore. The researchers measured the activity of 109,386 candidate CREs in both lab-grown human liver cells and the livers of live mice through a massively parallel reporter assay (MPRA). This identified a catalogue of functional CREs (fCREs) that were actively regulating gene expression in the liver.

They then found specific control switches that responded to bacterial signals by using MPRA to compare fCRE activity in mice with and without normal gut microbes. Experiments further showed how these metabolites could directly influence fCREs, including flipping certain switches responsible for controlling disease-linked genes. “We also found that gut microbes triggered the protective KEAP1/NFE2L2 antioxidant pathway, which helps liver cells handle stress and damage,” Chen said.

Analysing genomic data collected in Singapore, the researchers also identified a rare DNA variation, more common in people of East Asian ancestry, that increased the sensitivity of a microbe-responsive liver CRE. “This single DNA letter change acted like a ‘volume booster’. It made the switch significantly more sensitive, allowing the gut bacterial signals to turn nearby genes up much higher than usual,” said Chen.

These findings suggest that changes in one’s DNA can influence the liver’s response to gut microbiome signalling. To study this connection further, the researchers next hope to explore how DNA variations, different diets and gut microbiome composition interact to influence liver disease risk.

Moreover, they plan to test whether modulating these specific switches can prevent or reverse liver inflammation or cancer in preclinical models. Such insights, Chen said, could eventually inform personalised interventions designed to target the CREs or the bacterial metabolites that turn these switches on or off, impacting liver health via its communication line with the gut.

The A*STAR-affiliated researchers contributing to this research are from the A*STAR Genome Institute of Singapore (A*STAR GIS).

Want to stay up to date with breakthroughs from A*STAR? Follow us on Twitter and LinkedIn!

References

Zaratiana, C., M Y., Lee, Y.-A., L., Ong, A.B.L., Liu, T.Z.Y., et al. Gut microbiota modulation of regulatory DNA elements revealed by massively parallel functional characterization. Molecular Cell 86, 1708-1722.e9 (2026). | article

About the Researcher

Benson Chen is the Principal Investigator of the Epimetagenomic Lab at the A*STAR Genome Institute of Singapore (A*STAR GIS). He earned his PhD from the University of Massachusetts Medical School, USA, in 2015. His research focuses on developing chemical biology tools and innovative genomic technologies to elucidate the complex interplay between the gut microbiome and host gene regulation. Prior to joining A*STAR in 2022, he was a member of the ENCODE4 Consortium at the University of California San Diego, where he contributed to efforts to characterize the functions of non-coding DNA. His current work combines chemical biology, epigenomics, and functional genomics to uncover mechanisms linking diet, metabolism, and cancer development.

This article was made for A*STAR Research by Wildtype Media Group